RCT: Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer
22 Apr, 2021 | 08:15h | UTCSacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer – New England Journal of Medicine (link to abstract – $ for full-text)
Open access